TC-G 24 is a potent and selective glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50 = 17.1 nM) that can cross the blood-brain barrier (BBB); it is used in the study of various diseases, including type 2 diabetes, stroke, Alzheimer's disease, and other related disorders.